324: Genentech's cancer pivot, Pfizer's sickle cell withdrawal, and a new schizophrenia drug
The Readout Loud
From Cake Celebrations to Major Pharmaceutical News
This chapter begins with a cheerful conversation about a cake made after apple picking, highlighting a team member's absence. The mood shifts as the discussion turns to the serious news of Pfizer withdrawing its sickle cell disease treatment and its potential impact.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
